MX6A.F GRAND PHARM. GRP. HD-01

Healthcare Pharmaceuticals Frankfurt Exchange
0.4887 EUR
Close of Nov 12, 2026
0.4540 0.8828
Market cap
EUR 1.71B
P/E
11.8x
P/B
0.84x
ROE
7.3%
Dividend yield
3.98%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is MX6A.F undervalued?

Graham number
Price0.4887
Graham value0.7367
Discount33.7%

MX6A.F trades 33.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

GRAND PHARM. GRP. HD-01 fundamental analysis

No fundamental analysis for GRAND PHARM. GRP. HD-01 yet.

GRAND PHARM. GRP. HD-01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About GRAND PHARM. GRP. HD-01

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series …

Full company profile